News from the Drug Industry Documents Archive (DIDA)

Monday, August 1, 2011

Fake drug studies as marketing tools

A number of sources last month have exposed the pharmaceutical industry marketing tactic known as “seeding trials”. The purpose of a seeding trial is not to advance research but to make doctors familiar with a new drug by inviting them to take part in a research study and paying them for each subject they recruit. As the trial proceeds, the doctors gradually get to know the drug, making them more likely to prescribe it later.

  • Study of Neurontin: Titrate to Effect, Profile of Safety (STEPS) Trial: Narrative Account of a Gabapentin Seeding Trial
    Samuel Drumholz; David Egilman; Joseph Ross
    Archives of Internal Medicine 2011;171(12):1100-1107. doi:10.1001/archinternmed.2011.241

  • Useless Studies, Real Harm
    Carl Elliott, NY Times. July 29, 2011, page A27

1 comment: